Most Read Articles
Elvira Manzano, 16 Jan 2019
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
Pearl Toh, 12 Jan 2019
Two novel investigational topical agents show potential in improving symptoms of atopic dermatitis, according to early phase trials presented at the Inflammatory Skin Disease Summit (ISDS) in Vienna, Austria.
25 Jan 2019
Daylight photodynamic therapy (DLPDT) represents a promising treatment option for actinic keratoses, with the results of a meta-analysis showing that while comparable to conventional PDT in terms of efficacy, DLPDT is associated with less pain and high patient satisfaction.
27 Jan 2019
A treatment regimen containing oral tetracycline and nicotinamide plus topical clobetasol appears to be effective in the treatment of bullous pemphigoid, yielding better survival rates compared with prednisone, according to a study.

Podcast: Dr Michael Koren talks about the final report of the OSLER-1 study

21 Nov 2018
Podcast: Dr Michael Koren talks about the final report of the OSLER-1 study
Editor's Recommendations
Most Read Articles
Elvira Manzano, 16 Jan 2019
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
Pearl Toh, 12 Jan 2019
Two novel investigational topical agents show potential in improving symptoms of atopic dermatitis, according to early phase trials presented at the Inflammatory Skin Disease Summit (ISDS) in Vienna, Austria.
25 Jan 2019
Daylight photodynamic therapy (DLPDT) represents a promising treatment option for actinic keratoses, with the results of a meta-analysis showing that while comparable to conventional PDT in terms of efficacy, DLPDT is associated with less pain and high patient satisfaction.
27 Jan 2019
A treatment regimen containing oral tetracycline and nicotinamide plus topical clobetasol appears to be effective in the treatment of bullous pemphigoid, yielding better survival rates compared with prednisone, according to a study.